Domov › Rakovina hrubého čreva › Tennessee › Nashville
Klinické štúdie Rakovina hrubého čreva v meste Nashville, TN
16 štúdií pre Rakovina hrubého čreva hľadá účastníkov v zariadeniach v meste Nashville a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, Nashville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Prebieha náborFáza 3
- Henry-Joyce Cancer Clinic, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- Sarah Cannon Research Institue, Nashville
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Prebieha náborFáza 1/2
- Tennessee Oncology, PLLC, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Prebieha náborFáza 1/2
- GSK Investigational Site, Nashville
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Prebieha náborFáza 2/3
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Prebieha náborFáza 1
- Xencor Investigative Site, Nashville
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Prebieha náborFáza 1
- Sarah Cannon, SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- Vanderbilt University Medical Center, Nashville
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Prebieha náborFáza 2
- SCRI Oncology Partners, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site, Nashville
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute, Nashville
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Sarah Cannon Research Institute, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Sarah Cannon Research Institute, Nashville
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Prebieha náborObservačná štúdia
- Veterans Affairs Medical Center - Nashville, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Nashville
Štúdie Rakovina hrubého čreva v iných mestách
- Boston, MA22 štúdií
- New York City, NY22 štúdií
- Houston, TX20 štúdií
- Los Angeles, CA16 štúdií
- St. Louis, MO15 štúdií
- Arlington, VA15 štúdií
- Chicago, IL14 štúdií
- San Antonio, TX14 štúdií
- Baldwin Park, CA14 štúdií
- Baltimore, MD13 štúdií
- Tampa, FL13 štúdií
- Washington, DC12 štúdií
Iné štúdie v Nashville
- Nemalobunkový karcinóm pľúc97 štúdií
- Rakovina prsníka81 štúdií
- Metastatická rakovina70 štúdií
- Kolorektálny karcinóm69 štúdií
- Rakovina (všetky typy)65 štúdií
- Rakovina vaječníkov49 štúdií
- Rakovina prostaty43 štúdií
- Rakovina pľúc40 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku39 štúdií
- Rakovina pankreasu39 štúdií
- Rakovina endometria38 štúdií
- Melanóm33 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.